| dc.contributor.author | Scheppach, J | en_US |
| dc.contributor.author | Cleary, F | en_US |
| dc.contributor.author | Kim, L | en_US |
| dc.contributor.author | Hull, S | en_US |
| dc.contributor.author | Nitsch, D | en_US |
| dc.contributor.author | Wheeler, DC | en_US |
| dc.contributor.author | Caplin, B | en_US |
| dc.date.accessioned | 2019-11-27T13:05:36Z | |
| dc.date.issued | 2016-05 | en_US |
| dc.identifier.issn | 0931-0509 | en_US |
| dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/61584 | |
| dc.description | This is a pre-copyedited, author-produced version of an article accepted for publication in Nephrology Dialysis Transplantation following peer review. The version of record - Scheppach, J., et al. (2016). "SP285MORE THAN ONE THIRD OF RENAL PATIENTS UNDER PRIMARY CARE IN THE UK ARE NOT RECEIVING THE RECOMMENDED STATIN THERAPY FOR PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE." Nephrology Dialysis Transplantation 31(suppl_1): i183-i183. is available online at: https://doi.org/10.1093/ndt/gfw165.02 | en_US |
| dc.format.extent | 183 - 183 | en_US |
| dc.language.iso | en | en_US |
| dc.rights | All rights reserved | |
| dc.title | MORE THAN ONE THIRD OF RENAL PATIENTS UNDER PRIMARY CARE IN THE UK ARE NOT RECEIVING THE RECOMMENDED STATIN THERAPY FOR PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE | en_US |
| dc.type | Conference Proceeding | |
| dc.rights.holder | The Author 2016. Published by Oxford University Press on behalf of ERA-EDTA. | |
| pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000376653800468&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
| pubs.notes | Not known | en_US |
| pubs.publication-status | Published | en_US |
| pubs.volume | 31 | en_US |
| rioxxterms.funder | Default funder | en_US |
| rioxxterms.identifier.project | Default project | en_US |
